Newsletter | October 20, 2022

10.20.22 -- Amgen Report Finds Biosimilar Competition Saved US $21B

Featured Editorial
Industry Insights
Top Four Considerations For Tech Transfer Performance

Successful tech transfer is how long-term strategic CDMO relationships begin. A product’s continued success may hinge on this critical exchange of product data and required regulatory filings.

3 Steps To Optimize The Fed-Batch Process For mAb Production

We describe a straightforward way to achieve a high-performing, fed-batch process for a knockout cell line. This workflow improved titers 500% compared with CHO cell culture in basal medium.

8 Misconceptions On Collaborating To Benefit Your Drug Program

Review a few misconceptions about collaborating with Pfizer CentreOne and how they align with the values of courage, excellence, equity, and joy.

How Shorter Needles With Thinner Walls Are Set To Improve The Injection Experience In Chronic Care

This series of frequently asked questions covers the research and design mindset applied to the development of the BD Neopak XtraFlow solution and how the anticipated clinical benefits of 8 mm needles will support their broad adoption over time for subcutaneous drug delivery, particularly for use in chronic care settings.

Find The Right Intensification Strategy For Upstream, Downstream Processes

How do you know if an intensification approach will provide advantages? Three process intensification experts show how different intensification approaches affect outputs using different scenarios.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.